MONOVISC

Formula & Concentration

MONOVISC™ High Molecular Weight Hyaluronan

Manufacturer

JOM Pharmaceutical Services Inc.

Indications

Monovisc™ is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen).

Product Options

Package Size

NDC #

Presentation

88 mg

59676-0820-01

Prefilled syringe

Shelf Life and Storage

Store Monovisc™ in its original package at room temperature (below 77°F/25°C). DO NOT FREEZE.